New Vaccine Quality Assessment Assay Developed Using Conformation-Dependent Antibodies Coupled to SE-HPLC
Researchers have developed and validated a stability- and potency-indicating assay protocol for high-throughput quality assessment of vaccines consisting of recombinant virus- “like” particles (VLPs) using conformation-dependent antibodies coupled to size-exclusion high performance liquid chromatography (SE-HPLC).
Photo Credit: Kateryna Kon/Shutterstock.com
Researchers have developed and validated a stability- and potency-indicating assay protocol for high-throughput quality assessment of vaccines consisting of recombinant virus- “like” particles (VLPs) using conformation-dependent antibodies coupled to size-exclusion high performance liquid chromatography (SE-HPLC) (1).
Traditional vaccines utilizing attenuated or inactivated infectious agents often induce unpleasant side effects in their recipients, necessitating research into alternatives, and leading to the development of “subunit vaccines”. These vaccines do not contain live components of the pathogen, but instead contain recombinant protein antigens. Although cheaper to produce and safer to use than conventional vaccines, the recombinant proteins contained within these vaccines can suffer from poor immunogenicity and therefore require extensive testing to ensure effectiveness.
Subunit vaccines have been developed against viruses such as human papillomavirus (HPV), which is the most common cause of viral infections of the genital tract. Strains of HPV can be cancer causing, and have been found to be responsible for approximately 70% of cervical cancer and precancerous cervical lesions (2). The HPV vaccine is quadrivalent containing four types of non-infectious recombinant VLPs, however, currently ELISA remains the only approved in vitro potency testing assay for this vaccine. Despite good reproducibility and specificity, the protocol is time consuming, labour intensive, and sample volume demanding. These limitations raised the need for a more economic and industry friendly approach for quality assessment and batch release of HPV vaccine preparations.
Researchers developed an alternative method for vaccine evaluation using vacuum-immunoaffinity extraction (IAE) columns for sample preparation and IAE coupled to SE-HPLC for the determination of VLPs. The results were compared to the conventional ELISA assay and excellent specificity, sensitivity, and precision were found. The IAEâSEâHPLC assay protocol was demonstrated to be superior to ELISA, extensively reducing analysis time and cost.
References
- M.M. Mostafa et al., J. Chromatogr. B1032, 211–217 (2016).
- WHO fact sheet, Human Papillomavirus (HPV) and Cervical Cancer Fact SheetNo380, 2015 http://www.who.int/mediacentre/factsheets/fs380.
Best of the Week: Food Analysis, Chemical Migration in Plastic Bottles, STEM Researcher of the Year
December 20th 2024Top articles published this week include the launch of our “From Lab to Table” content series, a Q&A interview about using liquid chromatography–high-resolution mass spectrometry (LC–HRMS) to assess chemical hazards in plastic bottles, and a piece recognizing Brett Paull for being named Tasmanian STEM Researcher of the Year.
Using LC-MS/MS to Measure Testosterone in Dried Blood Spots
December 19th 2024Testosterone measurements are typically performed using serum or plasma, but this presents several logistical challenges, especially for sample collection, storage, and transport. In a recently published article, Yehudah Gruenstein of the University of Miami explored key insights gained from dried blood spot assay validation for testosterone measurement.
Determination of Pharmaceuticals by Capillary HPLC-MS/MS (Dec 2024)
December 19th 2024This application note demonstrates the use of a compact portable capillary liquid chromatograph, the Axcend Focus LC, coupled to an Agilent Ultivo triple quadrupole mass spectrometer for quantitative analysis of pharmaceutical drugs in model aqueous samples.
